J M SMUCKER Co (SJM) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-07-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-07-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | (m) | |
| Stock-based compensation | 26.80M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 826.20M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | (m) | (m) | $26.80M | $826.20M | (m) | (m) | (m) | (m) | (m) |
| 2026-04-30 | (m) | (m) | $23.60M | $360.20M | (m) | (m) | (m) | (m) | (m) |
| 2026-01-31 | (m) | (m) | $25.10M | $-683.40M | (m) | (m) | (m) | (m) | (m) |
| 2025-10-31 | (m) | (m) | $32.00M | $-729.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-07-31 | (m) | (m) | $30.00M | $-977.80M | (m) | (m) | (m) | (m) | (m) |
| 2025-04-30 | (m) | (m) | $29.90M | $-673.90M | (m) | (m) | (m) | (m) | (m) |
| 2025-01-31 | (m) | (m) | $33.20M | $331.20M | (m) | (m) | (m) | (m) | (m) |
| 2024-10-31 | (m) | (m) | $26.00M | $1.22B | (m) | (m) | (m) | (m) | (m) |
| 2024-07-31 | (m) | (m) | $27.70M | $1.35B | (m) | (m) | (m) | (m) | (m) |
| 2024-04-30 | (m) | (m) | $23.90M | $1.31B | (m) | (m) | (m) | (m) | (m) |
| 2024-01-31 | (m) | (m) | $30.20M | $266.30M | (m) | (m) | (m) | (m) | (m) |
| 2023-10-31 | (m) | (m) | $34.00M | $286.80M | (m) | (m) | (m) | (m) | (m) |
| 2023-07-31 | (m) | (m) | $22.80M | $281.30M | (m) | (m) | (m) | (m) | (m) |
| 2023-04-30 | (m) | (m) | $25.60M | $157.50M | (m) | (m) | (m) | (m) | (m) |
| 2023-01-31 | (m) | (m) | $18.40M | $1.09B | (m) | (m) | (m) | (m) | (m) |
| 2022-10-31 | (m) | (m) | $17.00M | $925.70M | (m) | (m) | (m) | (m) | (m) |
| 2022-07-31 | (m) | (m) | $24.90M | $944.10M | (m) | (m) | (m) | (m) | (m) |
| 2022-04-30 | (m) | (m) | $22.30M | $1.02B | (m) | (m) | (m) | (m) | (m) |
| 2022-01-31 | (m) | (m) | $23.00M | $960.50M | (m) | (m) | (m) | (m) | (m) |
| 2021-10-31 | (m) | (m) | $25.90M | $1.22B | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | $28.10M | $1.29B | (m) | (m) | (m) | (m) | (m) |
| 2021-04-30 | (m) | (m) | $28.70M | $1.39B | (m) | (m) | (m) | (m) | (m) |
| 2021-01-31 | (m) | (m) | $27.90M | $1.49B | (m) | (m) | (m) | (m) | (m) |
| 2020-10-31 | (m) | (m) | $26.50M | $1.38B | (m) | (m) | (m) | (m) | (m) |
| 2020-07-31 | (m) | (m) | $26.50M | $1.33B | (m) | (m) | (m) | (m) | (m) |
| 2020-04-30 | (m) | (m) | $26.80M | $1.22B | (m) | (m) | (m) | (m) | (m) |
| 2020-01-31 | (m) | (m) | $24.00M | $1.03B | (m) | (m) | (m) | (m) | (m) |
| 2019-10-31 | (m) | (m) | $23.90M | $958.60M | (m) | (m) | (m) | (m) | (m) |
| 2019-07-31 | (m) | (m) | $22.30M | $959.30M | (m) | (m) | (m) | (m) | (m) |
| 2019-04-30 | (m) | (m) | $20.70M | $928.60M | (m) | (m) | (m) | (m) | (m) |
| 2019-01-31 | (m) | (m) | $15.10M | $1.08B | (m) | (m) | (m) | (m) | (m) |
| 2018-10-31 | (m) | (m) | $13.20M | $1.03B | (m) | (m) | (m) | (m) | (m) |
| 2018-07-31 | (m) | (m) | $13.40M | $1.03B | (m) | (m) | (m) | (m) | (m) |
| 2018-04-30 | (m) | (m) | $15.40M | $1.04B | (m) | (m) | (m) | (m) | (m) |
| 2018-01-31 | (m) | (m) | $16.80M | $923.90M | (m) | (m) | (m) | (m) | (m) |
| 2017-10-31 | (m) | (m) | $19.60M | $998.90M | (m) | (m) | (m) | (m) | (m) |
| 2017-07-31 | (m) | (m) | $20.50M | $971.50M | (m) | (m) | (m) | (m) | (m) |
| 2017-04-30 | $58.10M | (m) | $22.00M | $1.03B | (m) | (m) | (m) | (m) | (m) |
| 2017-01-31 | (m) | (m) | $29.70M | $1.08B | (m) | (m) | (m) | (m) | (m) |
| 2016-10-31 | (m) | (m) | $33.30M | $1.16B | (m) | (m) | (m) | (m) | (m) |
| 2016-07-31 | (m) | (m) | $35.00M | $1.17B | (m) | (m) | (m) | (m) | (m) |
| 2016-04-30 | $58.80M | (m) | $34.60M | $1.15B | (m) | (m) | (m) | (m) | (m) |
| 2016-01-31 | (m) | (m) | $34.50M | $969.70M | (m) | (m) | (m) | (m) | (m) |
| 2015-10-31 | (m) | (m) | $27.80M | $906.50M | (m) | (m) | (m) | (m) | (m) |
| 2015-07-31 | (m) | (m) | $24.30M | $847.50M | (m) | (m) | (m) | (m) | (m) |
| 2015-04-30 | $32.50M | (m) | $23.50M | $772.00M | (m) | (m) | (m) | (m) | (m) |
| 2015-01-31 | (m) | (m) | $20.80M | $892.90M | (m) | (m) | (m) | (m) | (m) |
| 2014-10-31 | (m) | (m) | $22.70M | $901.30M | (m) | (m) | (m) | (m) | (m) |
| 2014-07-31 | (m) | (m) | $24.20M | $897.30M | (m) | (m) | (m) | (m) | (m) |
| 2014-04-30 | $24.30M | (m) | $22.90M | $919.00M | (m) | (m) | (m) | (m) | (m) |
| 2014-01-31 | (m) | (m) | $23.50M | $941.60M | (m) | (m) | (m) | (m) | (m) |
| 2013-10-31 | (m) | (m) | $23.10M | $936.40M | (m) | (m) | (m) | (m) | (m) |
| 2013-07-31 | (m) | (m) | $22.60M | $933.20M | (m) | (m) | (m) | (m) | (m) |
| 2013-04-30 | $24.70M | (m) | $21.30M | $910.40M | (m) | (m) | (m) | (m) | (m) |
| 2013-01-31 | (m) | (m) | $21.01M | $881.97M | $95.20M | (m) | (m) | 9.26× | Reported |
| 2012-10-31 | (m) | (m) | $19.66M | $824.03M | $94.57M | (m) | (m) | 8.71× | Reported |
| 2012-07-31 | (m) | (m) | $19.99M | $788.11M | $89.76M | (m) | (m) | 8.78× | Reported |
| 2012-04-30 | $21.93M | (m) | $21.71M | $778.28M | $81.30M | (m) | (m) | 9.57× | Reported |
| 2012-01-31 | (m) | (m) | $22.77M | $758.79M | $74.89M | (m) | (m) | 10.13× | Reported |
| 2011-10-31 | (m) | (m) | $24.51M | $771.39M | $69.42M | (m) | (m) | 11.11× | Reported |
| 2011-07-31 | (m) | (m) | $25.02M | $799.81M | $68.48M | (m) | (m) | 11.68× | Reported |
| 2011-04-30 | $20.98M | (m) | $24.33M | $784.27M | $69.59M | (m) | (m) | 11.27× | Reported |
| 2011-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-04-30 | $20.96M | (m) | $25.95M | $790.91M | $65.19M | (m) | (m) | 12.13× | Reported |
| 2010-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-04-30 | $14.50M | (m) | $22.11M | $452.27M | $62.48M | (m) | (m) | 7.24× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.